BDX stock touches 52-week low at $186.01 amid market shifts

Published 01/05/2025, 14:36
BDX stock touches 52-week low at $186.01 amid market shifts

In a challenging market environment, Becton Dickinson and Co. (NYSE:BDX) stock has recorded a new 52-week low, dipping to $186.01. According to InvestingPro data, the company maintains a "GOOD" financial health score, with particularly strong profitability metrics and a beta of just 0.38, indicating lower volatility than the broader market. The medical technology company, known for its wide array of medical devices and supplies, has faced headwinds that have pressured its stock price over the past year, culminating in a significant retreat from its previous levels. Despite the challenges, the company has maintained its impressive 54-year streak of dividend increases, with a current yield of 2.01%. This latest price point marks a stark contrast to the stock’s performance over the past year, with Becton Dickinson experiencing a 1-year change of -13.84%, reflecting broader market trends and investor sentiment in the healthcare sector. InvestingPro analysis suggests the stock is currently trading below its Fair Value, potentially presenting an opportunity for value investors. As stakeholders and analysts review the implications of this new low, the company’s strategic responses and market conditions in the coming months will be closely monitored. With analyst targets ranging from $245 to $325 and expected net income growth this year, detailed analysis and additional insights are available in the comprehensive Pro Research Report on InvestingPro.

In other recent news, Becton Dickinson reported its Q2 2025 earnings, showcasing a mixed performance. The company achieved an adjusted earnings per share (EPS) of $3.35, surpassing the forecast of $3.28, but revenue fell short at $5.27 billion against the anticipated $5.35 billion. Despite the revenue miss, the company highlighted its strategic investments in new product launches and U.S. manufacturing. Becton Dickinson also announced plans to invest $2.5 billion in U.S. manufacturing over the next five years. Analyst firms have noted the company’s ongoing challenges, including procurement pressures in China and research funding cuts. The company projects full-year revenue between $21.8 billion and $21.9 billion, with adjusted EPS guidance of $14.34 to $14.6. Becton Dickinson remains optimistic about organic growth improvements in the coming quarters.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.